In8Bio (INAB) Assets (2020 - 2026)
In8Bio (INAB) posted Assets of $26.3 million for Q1 2026, down 18.64% sequentially from $32.3 million in Q4 2025, and up 32.19% YoY from $19.9 million in Q1 2025.
In8Bio (INAB) Assets (2020 - 2026) Analysis & Trends
In8Bio has reported Assets for 7 years, with the latest figure at $26.3 million in Q1 2026.
- Quarterly Assets rose 32.19% year-over-year to $26.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.3 million (up 32.19% YoY) and the FY2025 annual result came in at $32.3 million, up 54.13% from the prior year.
- Assets eased to $26.3 million in Q1 2026 per INAB's latest filing, from $32.3 million in the prior quarter.
- Over five years, Assets peaked at $38.4 million in Q3 2022 and troughed at $16.0 million in Q3 2024.
- A 5-year average of $26.7 million and a median of $26.2 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets soared 76.43% in 2022, then sank 39.08% in 2024.
- Over 5 years, Assets stood at $33.0 million in 2022, then increased by 2.03% to $33.7 million in 2023, then plunged by 37.87% to $20.9 million in 2024, then jumped by 54.13% to $32.3 million in 2025, then dropped by 18.64% to $26.3 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $26.3 million, $32.3 million, and $16.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 19.82 Bn |
| 10 | In8Bio | 23.11 Mn | 23.11 Mn | - | 21.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.75 Mn |
| Mar 31, 2026 | 26.27 Mn |
| Dec 31, 2025 | 32.28 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 19.37 Mn |
| Mar 31, 2025 | 19.87 Mn |
| Dec 31, 2024 | 20.94 Mn |
| Sep 30, 2024 | 15.97 Mn |
| Jun 30, 2024 | 22.50 Mn |
| Dec 31, 2023 | 33.71 Mn |
| Sep 30, 2023 | 26.21 Mn |
| Jun 30, 2023 | 29.72 Mn |
| Mar 31, 2023 | 24.68 Mn |
| Dec 31, 2022 | 33.04 Mn |
| Sep 30, 2022 | 38.38 Mn |
| Jun 30, 2022 | 30.99 Mn |
| Mar 31, 2022 | 36.54 Mn |
| Dec 31, 2021 | 42.22 Mn |
| Sep 30, 2021 | 47.13 Mn |
| Jun 30, 2021 | 17.56 Mn |